Review



mss-type mouse colon carcinoma cell lines colon 26 (ct26)  (Procell Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Procell Inc mss-type mouse colon carcinoma cell lines colon 26 (ct26)
    Effect of PD-1 antibody immunotherapy on the diversity of <t>CT26</t> tumor-bearing mice with different gut microbiome. (A) Schematic diagram of mouse model experiment process and sample collection and analysis. (B) Tumor size of mice at the end of immunotherapy. (C) Tumor size of mice at the end of immunotherapy in the presence of different antibiotic regimen in each group.
    Mss Type Mouse Colon Carcinoma Cell Lines Colon 26 (Ct26), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mss-type mouse colon carcinoma cell lines colon 26 (ct26)/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    mss-type mouse colon carcinoma cell lines colon 26 (ct26) - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway"

    Article Title: Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway

    Journal: Frontiers in Microbiology

    doi: 10.3389/fmicb.2020.00814

    Effect of PD-1 antibody immunotherapy on the diversity of CT26 tumor-bearing mice with different gut microbiome. (A) Schematic diagram of mouse model experiment process and sample collection and analysis. (B) Tumor size of mice at the end of immunotherapy. (C) Tumor size of mice at the end of immunotherapy in the presence of different antibiotic regimen in each group.
    Figure Legend Snippet: Effect of PD-1 antibody immunotherapy on the diversity of CT26 tumor-bearing mice with different gut microbiome. (A) Schematic diagram of mouse model experiment process and sample collection and analysis. (B) Tumor size of mice at the end of immunotherapy. (C) Tumor size of mice at the end of immunotherapy in the presence of different antibiotic regimen in each group.

    Techniques Used:

    Gut microbiome diversity is associated with response to PD-1 antibody immunotherapy in CT26 tumor-bearing mice. (A) Venn diagram of the total number of species shared between the three groups. (B) Hierarchical clustering tree on OUT level. (C) The community map of dominant species in three group at the level of species, the columns with different colors represent different species, and the length of the columns represents the proportion of species. (D) Bar plot of compositional differences at species level in the gut microbiome of three groups of mice by one-way ANOVA. (E) Circos of sample and species: a visual circle diagram describing the correspondence between samples and species.
    Figure Legend Snippet: Gut microbiome diversity is associated with response to PD-1 antibody immunotherapy in CT26 tumor-bearing mice. (A) Venn diagram of the total number of species shared between the three groups. (B) Hierarchical clustering tree on OUT level. (C) The community map of dominant species in three group at the level of species, the columns with different colors represent different species, and the length of the columns represents the proportion of species. (D) Bar plot of compositional differences at species level in the gut microbiome of three groups of mice by one-way ANOVA. (E) Circos of sample and species: a visual circle diagram describing the correspondence between samples and species.

    Techniques Used:



    Similar Products

    90
    Procell Inc mss-type mouse colon carcinoma cell lines colon 26 (ct26)
    Effect of PD-1 antibody immunotherapy on the diversity of <t>CT26</t> tumor-bearing mice with different gut microbiome. (A) Schematic diagram of mouse model experiment process and sample collection and analysis. (B) Tumor size of mice at the end of immunotherapy. (C) Tumor size of mice at the end of immunotherapy in the presence of different antibiotic regimen in each group.
    Mss Type Mouse Colon Carcinoma Cell Lines Colon 26 (Ct26), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mss-type mouse colon carcinoma cell lines colon 26 (ct26)/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    mss-type mouse colon carcinoma cell lines colon 26 (ct26) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Effect of PD-1 antibody immunotherapy on the diversity of CT26 tumor-bearing mice with different gut microbiome. (A) Schematic diagram of mouse model experiment process and sample collection and analysis. (B) Tumor size of mice at the end of immunotherapy. (C) Tumor size of mice at the end of immunotherapy in the presence of different antibiotic regimen in each group.

    Journal: Frontiers in Microbiology

    Article Title: Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway

    doi: 10.3389/fmicb.2020.00814

    Figure Lengend Snippet: Effect of PD-1 antibody immunotherapy on the diversity of CT26 tumor-bearing mice with different gut microbiome. (A) Schematic diagram of mouse model experiment process and sample collection and analysis. (B) Tumor size of mice at the end of immunotherapy. (C) Tumor size of mice at the end of immunotherapy in the presence of different antibiotic regimen in each group.

    Article Snippet: The MSS-type mouse colon carcinoma cell lines colon 26 (CT26) (purchased from Procell Life Science & Technology Co., Ltd. Cat:CL-0071) were cultured in RPMI1640 medium (GIBCO) supplemented with 10% heat-inactivated fetal calf serum at 37°C in a 5% CO 2 incubator.

    Techniques:

    Gut microbiome diversity is associated with response to PD-1 antibody immunotherapy in CT26 tumor-bearing mice. (A) Venn diagram of the total number of species shared between the three groups. (B) Hierarchical clustering tree on OUT level. (C) The community map of dominant species in three group at the level of species, the columns with different colors represent different species, and the length of the columns represents the proportion of species. (D) Bar plot of compositional differences at species level in the gut microbiome of three groups of mice by one-way ANOVA. (E) Circos of sample and species: a visual circle diagram describing the correspondence between samples and species.

    Journal: Frontiers in Microbiology

    Article Title: Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway

    doi: 10.3389/fmicb.2020.00814

    Figure Lengend Snippet: Gut microbiome diversity is associated with response to PD-1 antibody immunotherapy in CT26 tumor-bearing mice. (A) Venn diagram of the total number of species shared between the three groups. (B) Hierarchical clustering tree on OUT level. (C) The community map of dominant species in three group at the level of species, the columns with different colors represent different species, and the length of the columns represents the proportion of species. (D) Bar plot of compositional differences at species level in the gut microbiome of three groups of mice by one-way ANOVA. (E) Circos of sample and species: a visual circle diagram describing the correspondence between samples and species.

    Article Snippet: The MSS-type mouse colon carcinoma cell lines colon 26 (CT26) (purchased from Procell Life Science & Technology Co., Ltd. Cat:CL-0071) were cultured in RPMI1640 medium (GIBCO) supplemented with 10% heat-inactivated fetal calf serum at 37°C in a 5% CO 2 incubator.

    Techniques: